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Staphylococcus sciuri are important human pathogens responsible for endocarditis, peritonitis, septic shock, urinary tract
infection, pelvic inflammatory disease and wound infections. However, little information is known regarding the pathogenicity
of S. sciuri to animals. From the pericardial fluid of a diseased piglet with exudative epidermitis (EE), we isolated a strain of
Staphylococcus in pure culture. Surprisingly, this isolate was a member of S. sciuri rather than S. hyicus as identified by its
biochemical traits and also by analysis of 23S ribosomal DNA using Internal Transcribed Spacer PCR. In addition, inoculation of
newborn piglets with 1610
10 CFU of the isolate by oral feeding or intra-muscular injection successfully reproduced EE in
piglets, which suggested that the oral intake of the pathogen by the animals is one of the major routes of exposure. These
unexpected findings prioritized S. sciuri as important zoonotic agents, which may have ramifications for human medicine.
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in Piglets. PLoS ONE 2(1): e147. doi:10.1371/journal.pone.0000147
INTRODUCTION
Exudative epidermitis (EE) in pigs, also called Greasy Pig Disease,
is a communicable skin disease caused by pathogenic strains of
staphylococci. This disease is mostly seen as an acute or peracute
infection in suckling and newly weaned piglets although it may
occur as a chronic infection in adult [1–4]. The diseased piglet
develops a generalized exudative epidermitis and may die within
a few days due, at least in part, to dehydration. The most
commonly seen causative agent for this disease was Staphylococcus
hyicus, which produced secretory exfoliative toxins as the major
factors to cause skin lesions [5]. At least six exfoliative toxins, ExhA
through D, ShetA and ShetB, have been described so far [6–8]
and their existence are species-dependent [9]. In addition to
epidermitis, S. hyicus may induce mastitis in cow [10,11],
polyarthritis in pig [12,13] and reproductive failure in sow [14].
Exudative epidermitis shared similar histopathology with the
human infection called the Staphylococcus aureus scalded skin
syndrome (SSSS) in terms of blister formation and exfoliation of
the skin caused by splitting of the skin at the granular layer of the
epidermis [15], which may be accounted for by the production of
similar exfoliative toxins by S. hyicus and S. aureus [16].
S. hyicus is generally recognized as the causative agent of EE,
however the other species of Staphylococcus may also cause this
disease as proposed by a recent publication that experimental
inoculation with a strain of S. chromogenes VA654 by s.c. route
induced EE in weaned pigs, which displayed an intraepidermal
pustular dermatitis with exocytosis, exudation (crust formation),
erosion, hyperkeratosis and acanthosis together with perivascular
cellular infiltrations in dermis [17]. As S. chromogenes VA654 was
originally isolated from the skin of a healthy pig, although the
production of the exfoliative toxin (ExhB) could be detected at
both DNA and protein levels, experimental inoculation of pigs
with this strain only indicated the potential of S. chromogenes as
a causative agent for EE. Since no field case of S. chromogenes
infections in pigs has been described, the clinical evidence is still
required to establish S. chromogenes as a pathogen for EE. Thus, no
other species of Staphylococcus beyond S. hyicus has been
previously described as a pathogen for EE in pigs. Here we report
that a highly pathogenic strain of Staphylococcus sciuri HBXX06
caused an acute form of EE in piglets in both natural and
experimental conditions, which suggested that the isolate of S. sciuri
HBXX06 was a new emerging pathogen for EE in pigs.
RESULTS
Fatal Exudative Epidermitis occurred in piglets
Exudative epidermitis occurred in the suckling piglets on
a conventional pig farm with 172 sows in Hebei province in the
fall of 2005 through May of 2006. The diseased piglets, which
were born healthy, began to show clinical signs as early as 1 days
following birth, displaying skin reddening, exfoliation, exudation
and crusting, and succumbed to death within 2–4 days. The
survivals were covered with brownish greasy layers (Figure 1A and
1B). As shown in Figure 1C, the mortality was 13% (3/23) in the
beginning of the outbreak and reached up to 84% (80/95) within 6
months while the morbidity began with 33% (1/3) and reached up
to 68% (54/80) in the spring of 2006. The nursing sow of diseased
piglets manifested no other clinical signs than localized transient
rashes or slight EE on the abdomen skin but recovered in a few
days.
A strain of Staphylococcus sciuri carrying Exh-C
gene was isolated from a diseased piglet with EE
A strain of Staphylococcus, which we named HBXX06, was
isolated in pure culture from the pericardial fluid of a moribund
piglet and was identified as S. sciuri by morphological and
biochemical examinations. The isolate displayed the morphology
of Staphylococcus under the microscope, shaped as Gram staining
positive cocci in clump (Figure 2A) and showed the biochemical
characteristics of S. sciuri, which was up to 95% in common with
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importantly, this strain of staphylococcus was coagulase negative,
resistant to novobiocin but sensitive to Polymycin B, which
differentiated S. sciuri from S. hyicus (Table 2). These results
indicated that the isolate HBXX06 was a strain of S. sciuri.A si t
has never been reported that S. sciuri could cause EE in pigs, this
finding was quite unexpected. To confirm the results of bio-
chemical examination, we further analyzed the strain S. sciuri
HBXX06 at a molecular level using ITS-PCR assay and also
examined the exfoliative toxins of the bacteria. As shown in
Figure 2B, Strain HBXX06 showed four bands between 400 and
600 bp, which did not fit the ITS-PCR pattern of any coagulase-
negative staphylococci tested by Couto and his colleagues [18].
This result suggested that S. sciuri HBXX06 may be a new
subspecies of S. sciuri. Using specific primers for the amplification
of exfoliative toxins, we found that HBXX06 carried Exh-C in its
genome DNA (Figure 2C). In addition, specific band of 23s could
also be amplified in the PCR assay, which confirmed the isolate as
a member of S. sciuri at a molecular level (Figure 2C). Therefore,
these results established the clinical isolate HBXX06 as an
emerging member of S. sciuri group at both cellular and molecular
levels.
S. sciuri HBXX06 was highly pathogenic to piglets
and mice
In order to determine whether the newly-isolated stain of S. sciuri
HBXX06 was a causative agent for EE, we experimentally
infected new born piglets with the isolate HBXX06 to reproduce
the EE. As expected, the piglets inoculated with S. sciuri HBXX06
at a dose of 1610
10 CFU/head via oral feeding or i.m. injection
showed fatal exudative epidermitis. All piglets in i.m. injection
group (n=3) died 12 hours post infection (Figure 3A). Piglets in
oral feeding group started to show clinical signs of EE on the
second day and died 4 days post infection (Figure 3B through 3D).
The bacteria were recovered from the skin as well as the lung,
lymph nodes and spleen of the infected piglets. The isolate showed
the same biochemical traits (data not shown) and ITS-PCR
pattern as the inoculums (Figure 2B). These results demonstrated
that S. sciuri HBXX06 was highly pathogenic to the newborn
piglets.
Figure 1. Clinical case of Exudative Epidermitis (EE) in piglets.
A–B. Skin lesions (indicated by arrows) of five-day-old piglets with EE. C.
Morbidity and mortality of suckling piglets from September of 2005
(n=23), December of 2005 (n=33) through March of 2006 (n=95).
doi:10.1371/journal.pone.0000147.g001
Figure 2. Gram’s staining and molecular identification of Staphylo-
coccus isolate.
A. Gram’s staining of the clinical Staphylococcus isolate. B. Identification
of Staphylococcus subspecies by ITS-PCR analysis of ribosomal DNA in
the isolates from natural EE (Lane 1) and experimental EE (Lane 2). C.
Examination of exfoliative toxin gene of the Staphylococcus isolate by
PCR. Lanes 1 through 5 represent the PCR products of Exh-A, Exh-B,
Exh-C, Exh-D and 23s ribosomal DNA, respectively.
doi:10.1371/journal.pone.0000147.g002
Figure 3. Reproduction of EE in newborn piglets inoculated with S.
sciuri HBXX06 via i.m. injection or oral feeding.
A. Four out of six newborn piglets treated with S. sciuri HBXX06 via i.m.
injection or oral feeding at the dose of 1610
10 CFU per pig succumbed
to death within 24 hours post infection. B–D. The skin lesions (indicated
by arrows) of the survivals of the piglets on days 2, 3 and 4 respectively
following oral feeding with 1610
10 CFU per piglet.
doi:10.1371/journal.pone.0000147.g003
Staphylococcus and Epidermitis
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piglets could be generalized to other animals, we infected 7 weeks
old Balb/C mice with the same bacterial isolate via i.p. injection.
As shown in Figure 4, most of the mice receiving the dose of
greater than 1610
8 CFU/mouse via i.p. injection died within
24 hour while the controls injected with PBS survived. These
results clearly demonstrated that S. sciuri HBXX06 was highly
pathogenic to piglets and mouse, which provided novel evidence
that some strain of S. sciuri may cause EE in pigs in experimental
conditions and the mice may be used as a model to investigate into
the pathogenesis of S. sciuri HBXX06 in animals
DISCUSSION
Members of the S. sciuri group are widely distributed in nature, and
they can be isolated from a variety of animals and the products of
animal origin [19–21] as well as from human [22,23], but most of
them are apathogenic to animals. However they are important
human pathogens responsible for?endocarditis [24], peritonitis
[25], septic shock [26], urinary tract infection [27], pelvic
inflammatory disease [28] and wound infections [29,30]. Cur-
rently little information is known regarding the pathogenicity of S.
sciuri in animals. It has been reported that some pathogenic strains
of S.sciuri were responsible for mastitis in ruminants such as goats
[31] and cow [32], which suggested that some members of S.sciuri
possesses pathogenic potentials. In the present study, we reported
that an isolate from an acute case of EE in piglets, identified as
a member of S. sciuri group, was highly pathogenic to both piglets
and mice.
Of note, the sows with diseased piglets displayed transient rashes
and slight exudative epidermitis at abdomen before delivery,
which suggested that the pathogenic strain of S.sciuri primarily
transmit by contact. We hypothesized that the newborns might
have picked up the pathogenic S. sciuri from contact with the
mother when suckling or licking, by which large amount of the
bacteria might have invaded the piglet by oral route. Therefore, in
addition to inoculation of the animals by injection [17], we
infected the newborn piglets via oral feeding. Our success in
reproduction of fatal EE in piglet by oral infection strongly
supported our assumption that the infection with S.sciuri HBXX06
by oral route might be the major mode of transmission for EE in
piglets.
S. hyicus has been generally recognized as a causative agent for
EE in pigs, however recently it has been reported that S. chromogenes
could cause this disease in experimental condition[17]. Since no
field case of S. chromogenes infections in pigs has been described, the
clinical evidence is still required to establish S. chromogenes as
a pathogen for EE in field condition. Our findings that S. sciuri
HBXX06 could cause fatal EE in piglets in both field and
experimental conditions greatly contributed to the further under-
standings of staphylococcus as pathogens responsible for EE in
pigs.
The typical features of S. sciuri are coagulase negative, oxidase
positive and novobiocin-resistant[33–35]. The isolate HBXX06
met these requirements. Besides, the PCR assay also confirmed the
bacteria HBXX06 as a member of S. sciuri (Figure 2C). These
results clearly indicated that the isolate HBXX06 is a member of S.
sciuri family. However its ITS-PCR pattern did not match any of
the coagulase negative staphylococci in the previous report [36],
Which suggested that S. sciuri HBXX06 might have emerged as
a new subspecies of S. sciuri. Since the S. sciuri group consists of
Staphylococcus sciuri subsp. carnaticus, Staphylococcus sciuri subsp.
rodentium, Staphylococcus sciuri subsp. sciuri, Staphylococcus lentus, and
Staphylococcus vitulinus [37,38], more efforts will be required to
elucidate the genotype of this isolate.
Exfoliative toxins are critical factors in the pathogenesis of EE
in pigs. The genes encoding four different exfoliative toxin from
S. hyicus (ExhA, ExhB, ExhC, and ExhD) were cloned and
sequenced [39]. The presence of different exfoliative toxins in
staphylococci could be examined using PCR. It was shown that
ExhA, ExhB, ExhC and ExhD had been detected in 20, 33, 18
and 22%, respectively, of 60 cases of EE investigated [40]. It
was also reported that one or more exfoliative toxins produced
by isolates of S. hyicus from different countries could be detected
[6]. Dakic and his colleagues examined the genes encoding
staphylococcal enterotoxins (sea to see, seg, and seh), toxic shock
syndrome toxin 1 (tst), and exfoliative toxins (eta and etb) in
a panel of 48 Staphylococcus sciuri group isolates from animals and
did not find any these genes [41]. In Another study, one hundred
and twenty-one isolates from human and animals were examined
for biofilm formation, hemagglutination, presence of clumping
factor, production of spreading factors and exotoxins, cytotoxicity
and capacity to stimulate nitric oxide production, and it was
found that a wide spectrum of possible virulence determinants
of S. sciuri existed [42], however their exact contribution to
virulence of this bacterium in vivo remains to be determined. In
the present study, we showed that S. sciuri HBXX06 harbored
the gene encoding Exh-C (Figure 2C). These results suggest that
the Exh-C might be one of these toxic genes involved in
pathogenesis of EE piglets infected with S. sciuri HBXX06. As
such, several questions need to be addressed, for example, where
did the pathogenic strain of S. sciuri HBXX06 come from? What
virulent factors S. sciuri HBXX06 has? What are their exact roles
in the pathogenesis of acute EE in piglets? and what is the
relationship of this bacterium to S.hyicus, the causative agent for
EE in pigs?
In summery, we isolated an emerging strain of S. sciuri from the
pericardial fluid of a diseased piglet with EE and succeeded in
reproduction of fatal EE in piglet with the isolate, which clearly
established that some member of S. sciuri may act as an important
causative agent to cause fatal EE in piglets. These findings
prioritized S. sciuri as important zoonotic agents, which may have
ramifications for human medicine.
Figure 4. The survival rate of Balb/C mice post infection with S. sciuri
HBXX06.
Thirty 7-week old male Balb/C mice were divided into 6 groups with 5
mice each. Mice were infected with S. sciuri HBXX06 or PBS as controls
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Investigation of the EE’s epidemiology on the farm
Clinical symptoms of EE were recorded based on the gross lesions
and necropsy of the piglets from a conventional pig-rearing farm
in Hebei province of China. Diseased pigs were sacrificed for
pathological examination and isolation of pathogens following
euthanasia. All procedures were approved by the animal care and
use committee of China Agricultural University.
Aetiological isolation and inoculum preparation
Swab samples were collected from the pericardial fluid of
a diseased piglet with EE. The isolate was grown aerobically on
nutrient agar (Land Bridge Technology Co., Ltd, Beijing) or
Manitol salt agar base medium (Aoboxing Universeen Bio-Tech
CO., LTD, Beijing) at 37uC for 17–24 h. The isolate was
replicated in Nutrient Broth Medium (Aoboxing Universeen Bio-
Tech CO., LTD, Beijing). Log-phase growing cultures were
washed twice with PBS and stored at 270uC until use.
Identification of the clinical isolate
(i) Cellular identification of the Staphylococcus isolate by bio-
chemical characteristics and antibiotic sensitivity test: The clinical
isolate was examined for members of the family Micrococcaceae
by means of the colony morphology and pigmentation, Gram’s
staining and catalase test, and further tested for biochemical traits
including oxidase (Land Bridge Technology Co., Ltd, Beijing) and
coagulase production, Novobiocin and Polymyxin B sensitivity
and others using TH-16S bacteria coding system (Beijing Land
Bridge Technology, Beijing). (ii) Molecular identification of the
Staphylococcus isolate by ITS-PCR: DNA was isolated via
commercial DNA Extraction Kit per manufacturer’s instruction
(TianGen Biotech (Beijing) Co., Ltd, Beijing). The ITS-PCR was
performed as previously described [43] with some modifications,
using primers G1 (5-GAAGTCGTAACAAGG) and L1 (5-
CAAGGCATCCACCGT) (Shanghai Sangon Biological Engi-
neering & Technology and Service Co., Ltd, Beijing). Amplifica-
tion reaction was performed on Techne TC512 Gene Amp PCR
System (Techne Corporation, UK). The program consisted of an
initial denaturation step at 94uC for 5 min and 30 amplification
cycles, each with 30 seconds at 94uC, 1 min at 55uC and 1 min at
72uC, followed by an additional extension step at 72uC for 10 min.
Amplification products were resolved for 2 h in 2% agarose gels
(ShanghaiAiyito Bio-instrument Co., Ltd) in TAE buffer contain-
ing 0.04 M Tris-acetate and 0.001 M EDTA (pH 8), after
supplemented with 0.06ml of SYBR Green I Loading buffer
(Beijing SBS Genetech Co., Ltd, Beijing) per ml. The standard
DNA ladder marker was purchased from TianGen Biotech
Company (Beijing). After photography by AlphaImager (Alpha
Innotech, Beijing), DNA patterns were visually analyzed [44].
Examination of genes encoding Staphylococcus of
exfoliative toxins by PCR
The PCR was performed as previously described [45], using
primers listed in Table 1. DNA was amplified by an initial
denaturation at 94uC for 5 min followed by 30 cycles of
30 seconds at 94uC, 1 min at 56uC and 30 seconds at 72uC.
The PCR reaction was completed by 10 min incubation at 72uC
for the full extension of the PCR products. Amplification products
were resolved in 2% agarose gel with the standard DNA ladder
markers (TianGen Biotech (Beijing) Co., Ltd, Beijing).
Experimental infection in mice
Thirty 7-week old male Balb/C mice were divided into 6 groups
with 5 mice each. Six groups of mice were inoculated respectively






7 CFU and 1610
6 CFU in
0.2 ml of sterile Phosphorus saline (PBS) per mouse via
intraperitoneal injection. Livers, spleens, kidney and pancreases
were removed from the infected mice at different time points after
Table 2. Biochemical traits of the clinical staphylococcus






















































































































Table 1. Oligonucleotide primers used in the PCR
..................................................................................................................................................
Gene amplified Primer name Sequence(59–39) PCR products size(bp)
ExhA MU4FA, MU3RA GCTACTGGTTTTGTAGTTTCAC GTAACCTACAACTCTTAGAACC 316
ExhB F2EB, MU3RB AACACGCCAATAGAGAATGTATCAC, TATCAAATCTTATACCAGTTAGAATATCTCC 717
ExhC MU3FC, MU4RC GAATAAATATTATGGAGTCTCTCCTGATC, CCATAGTATTTCAATCCAAAATCAGTAC 525
ExhD F2ED, MU3RD GAACAAATATAATGGAAGAAACCCAC, GATTTCCCTACGTGAATACCTACAATAC 588
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examination of bacterial presence [46].
Experimental infection in pigs
Three out of nine newborn Changbai piglets in the same litter
were experimentally infected with the clinical isolate via intra-
muscular injection, another three were infected by oral feeding
route and the rest three were injected with sterile PBS as the
controls. The piglets were not allowed to suckle following birth
until 45 minutes post infection. Cotton swab samples from the skin
behind the right ear were collected from each of the experimental
animals for microbiological examination. Each piglet in infection
groups received 1610
10 CFU of the bacterial isolates in 1 ml
sterile PBS either via i.m. injection or oral feeding route. The
piglets were clinically observed throughout the experiment.
Clinical signs were recorded and necropsy was performed
immediately after euthanasia. Samples for aetiological examina-
tion were collected from affected skin, liver, spleen and kidney
from each pig and plated on Manitol Salt Agar base medium.
Colony on the Manitol Salt Agar was then subjected to
identification by biochemical test and also by PCR for the
presence of exfoliative toxins and ITS PCR analysis of 23S
ribosomal DNA as described above.
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